Caliway Biopharmaceuticals Co., Ltd. (6919.TWO)
TWD 571.0
(-2.89%)
TWD 571.0
(-2.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 85.55 Million TWD | 24.31% |
| 2022 | 68.82 Million TWD | 0.85% |
| 2021 | 68.24 Million TWD | -62.18% |
| 2020 | 180.45 Million TWD | 0.44% |
| 2019 | 179.65 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 123.99 Million TWD | 44.94% |
| 2024 Q2 | 87.81 Million TWD | -29.18% |
| 2023 FY | 85.55 Million TWD | 24.31% |
| 2023 Q3 | 85.55 Million TWD | 18.51% |
| 2023 Q2 | 72.19 Million TWD | 0.0% |
| 2023 Q4 | 85.55 Million TWD | 0.0% |
| 2023 Q1 | - TWD | -100.0% |
| 2022 Q3 | 68.82 Million TWD | 0.0% |
| 2022 Q4 | 68.82 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 85.338% |
| Level Biotechnology Inc. | 273.2 Million TWD | 68.685% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 37.926% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 56.676% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 93.557% |
| GlycoNex Incorporation | 276.39 Million TWD | 69.047% |
| VBI | 21.25 Million TWD | -302.583% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 72.728% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 83.377% |
| Visgeneer Inc. | 185.6 Million TWD | 53.906% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 93.534% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 88.328% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 28.623% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 96.191% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -1192.732% |
| Enimmune corporation | 173.46 Million TWD | 50.679% |
| TaiRx, Inc. | 60.62 Million TWD | -41.118% |
| CHO Pharma, Inc. | 110.83 Million TWD | 22.808% |
| EirGenix Inc. | 1.14 Billion TWD | 92.529% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 23.6% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 83.305% |
| Lin BioScience, Inc. | 167.73 Million TWD | 48.994% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 8.708% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -35.725% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 31.409% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 46.881% |
| RBC Bioscience Corporation | 513.08 Million TWD | 83.326% |
| BiOptic Inc. | 170.56 Million TWD | 49.841% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -102.934% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -267.891% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -219.073% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 91.222% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -1123.234% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -303.058% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 76.773% |
| Neith Corporation | 17.43 Million TWD | -390.753% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -973.169% |
| NaviFUS Corp. | 53.4 Million TWD | -60.209% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 82.232% |
| Sinew Pharma Inc. | 39.71 Million TWD | -115.423% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -47.406% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 76.527% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 62.426% |
| AP Biosciences Inc | 106.65 Million TWD | 19.782% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 97.576% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -178.847% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 56.348% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 94.456% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 90.126% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -822.305% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -53.285% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 63.276% |
| TCI GENE Inc. | 155.54 Million TWD | 44.999% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -235.397% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -85.28% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 73.954% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -31.849% |
| PharmaEngine, Inc. | 91 Million TWD | 5.992% |
| Savior Lifetec Corporation | 457.95 Million TWD | 81.319% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 22.884% |
| OBI Pharma, Inc. | 650.44 Million TWD | 86.847% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 78.109% |
| Acepodia, Inc. | 384.47 Million TWD | 77.748% |